Novo-Nordisk (NVO)

Add to Watchlists
Create an Alert
55.18 -0.26  -0.47% NYSE Jul 2, 8:00PM Delayed 2m USD
View Full Chart
NVO Price Chart
View All Events

NVO Events

Date Type Description
04/30/2015 13:00 CEDT Misc Novo-Nordisk A/S First Quarter Earnings Conference Call in 2015
04/30/2015 Earnings Novo-Nordisk A/S First Quarter Earnings in 2015 Release
03/19/2015 Dividends Amount: 0.7300, Declared Date: Mar 04 2015, Pay Date: Mar 31 2015
01/30/2015 13:00 CEST Misc Novo-Nordisk A/S Fourth Quarter Earnings Conference Call in 2014
01/30/2015 Earnings Novo-Nordisk A/S Fourth Quarter Earnings in 2014 Release
10/30/2014 13:00 CEDT Misc Novo-Nordisk A/S Q3 2014 Earnings Conference Call
10/30/2014 Earnings Novo-Nordisk A/S Q3 2014 Earnings Results
08/07/2014 Earnings Novo-Nordisk A/S Q2 2014 Earnings Results
08/07/2014 Misc Novo-Nordisk A/S Q2 2014 Earnings Conference Call
View All Performance Charts

NVO Total Returns Comparison

This total returns chart shows the returns to an investor from both price appreciation and dividends (dividends are assumed to be reinvested). Novo-Nordisk is up 20.65% over the last year vs S&P 500 Total Return up 7.35%, Eli Lilly up 41.46%, and AstraZeneca down 10.72%.

PDF Report for NVO

Download NVO Pro Report PDF
Advertisement

NVO Profile

  • Sector: Healthcare
  • Industry: Biotechnology
  • Company Website: http://www.novonordisk.com
  • IR Website: http://www.novonordisk.com/investors.html
  • HQ Country: Denmark
  • HQ State/Province: N/A
  • Incorporation Country: Denmark
  • Incorporation State/Province: N/A
  • Est. Current Fiscal Quarter End: September 30, 2015
  • Est. Current Fiscal Year End: December 31, 2015
  • Last Fiscal Quarter End: March 31, 2015
  • Last Fiscal Year End: December 31, 2014
  • Next Earnings Release: N/A
  • NAICS: Pharmaceutical Preparation Manufacturing
  • NAICS Code: 325412
  • NAICS Industry: Pharmaceutical and Medicine Manufacturing
  • NAICS Sector: Manufacturing

Novo-Nordisk A/S is a healthcare company that is engaged in the discovery, development, manufacturing and marketing of pharmaceutical products. The Company has two business segments: diabetes care and biopharmaceuticals.

NVO Excel Add-In Codes

  • Name: =YCI("NVO","name")
  • Description: =YCI("NVO","description")
  • Sector: =YCI("NVO","sector")
  • Industry: =YCI("NVO","industry")
  • Est. Current Fiscal Year End: =YCI("NVO","fye")

To find the codes for any of our financial metrics, see our Complete Reference of Metric Codes.

Access our powerful Excel Add-in with a YCharts Professional Membership. Learn More.

Advertisement

You've hit the 10 page limit on YCharts.

Experience the power of YCharts.
Start your Free 7-Day Trial.

Start My Free Trial No credit card required.

Already a subscriber? Sign in.

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}
Start your free 7-Day Trial.

{{root.upsell.info.button_text}} No credit card required.

Already a subscriber? Sign in.